HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JUXTAPID safely and effectively. See full prescribing information for JUXTAPID. JUXTAPID® (lomitapide) capsules, fo

First Page		Document Content
Date: 2014-08-12 12:33:10 Lactams Organofluorides Organochlorides Hepatotoxicity Toxicology Liver function tests Jaundice Ticagrelor Zileuton Medicine Chemistry Hepatology		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JUXTAPID safely and effectively. See full prescribing information for JUXTAPID. JUXTAPID® (lomitapide) capsules, fo Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 830,96 KB Share Document on Facebook

	Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No DocID: 1rqYi - View Document
	Microsoft WordDOCX DocID: 1rnqZ - View Document
	Beilage 1: Arzneimittelmonographien DocID: 1rinj - View Document
	SAFETY DATA SHEET Page 1 of Total 6 Date of Issue: August 2016 SDS No. FMC/RAD/1 SECTION 1 DocID: 1rdYu - View Document
	imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib DocID: 1rdbp - View Document